Adverse Events during the Scleroderma Lung Study-Reference-Cited by-同舟云学术

Adverse Events during the Scleroderma Lung Study

Published:2011-05 Issue:5 Volume:124 Page:459-467
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Furst Daniel E.,Tseng Chi-Hong,Clements Philip J.,Strange Charlie,Tashkin Donald P.,Roth Michael D.,Khanna Dinesh,Li Ning,Elashoff Robert,Schraufnagel Dean E.

Publisher

Elsevier BV

Subject

General Medicine

Reference14 articles.

1. Cyclophosphamide versus placebo in scleroderma lung disease;Tashkin;N Engl J Med,2006

2. Follow-up HRCT after treatment of scleroderma-interstitial lung disease with cyclophosphamide demonstrates evidence for treatment effect [abstract];Vasu;Am J Respir Crit Care Med,2008

3. Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies [abstract];Nannini;Arthritis Res Ther,2008

4. Immunosuppresants in rheumatology;Furst,2006

5. The measurement of dyspnea;Mahler;Chest,1984

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of Systemic Sclerosis–associated Interstitial Lung Disease: Evidence-based Recommendations. An Official American Thoracic Society Clinical Practice Guideline;American Journal of Respiratory and Critical Care Medicine;2024-01-15

2. Cyclophosphamide in Patients with Systemic Sclerosis–associated Interstitial Lung Disease: A Systematic Review and Meta-Analysis;Annals of the American Thoracic Society;2024-01

3. Treatment of Interstitial Lung Disease in Systemic Sclerosis;Scleroderma;2024

4. Diagnosis and management of primary heart involvement in systemic sclerosis;Current Opinion in Rheumatology;2023-11-08

5. Heterogeneity of determining disease severity, clinical course and outcomes in systemic sclerosis-associated interstitial lung disease: a systematic literature review;RMD Open;2023-11